Label-Free Parkinson's Disease Screening from Face and Voice through Mechanistic Interpretability

• URL: http://arxiv.org/abs/2608.08976v1
• Date: Mon, 10 Aug 2026 00:43:57 GMT
• Title: Label-Free Parkinson's Disease Screening from Face and Voice through Mechanistic Interpretability
• Abstract summary: Parkinson's disease (PD) is the second most common neurodegenerative disorder.<n>We propose a label-free face-plus-voice PD screen built entirely on frozen pretrained encoders.<n>We show that a synthetic-degradation CAA detector works when the cosine similarity between the synthetic and real disease directions exceeds zero.
• Score: 4.241413288920499
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Parkinson's disease (PD) is the second most common neurodegenerative disorder. Typical machine learning screening methods require PD labels, but the available data is limited by privacy concerns and the need for expert annotation. We propose a label-free face-plus-voice PD screen built entirely on frozen pretrained encoders--a face-expression Vision Transformer and HuBERT--in which no PD label touches any fit; the reference is training controls only. The voice modality uses a synthetic-dysarthria contrastive activation addition (CAA) direction built from time-stretch and breathy degradation of healthy speech; the face modality uses a k-nearest-neighbor anomaly score to the control embedding cluster. We introduce the alignment principle, a post-hoc analysis showing that a synthetic-degradation CAA detector works when the cosine similarity between the synthetic and real disease directions exceeds zero. Measured on the YouTubePD benchmark, this cosine is +0.37 for voice (CAA works, AUROC 0.765) and -0.48 for face (CAA fails; anomaly succeeds, AUROC 0.751). Equal-weight late fusion reaches AUROC 0.802 (95% CI [0.70,0.89]) with NPV 0.95, supporting a rule-out triage interpretation. An overfitting audit shows the voice detector transfers cleanly, while the face-side--and thus fused--AUROC is potentially optimistic pending external validation.

Related papers

• CARDEA: Auditable Reasoning Grounded in Spatial Evidence for End-to-End Coronary Angiography Interpretation [0.0]
  Existing AI systems can improve consistency but lack auditable decision processes.<n>We developed CARDEA, a unified large vision-language model that serves as the inference core of a CAG pipeline.<n> CARDEA runs an end-to-end CAG pipeline from raw multiview videos through selection to study-level diagnosis.
  arXiv  Detail & Related papers  (2026-09-07T02:01:27Z)
• Physiological Signals as a Forensic Modality for Talking-Face Deepfake Detection [0.0]
  Talking-face (TF) deep-swap generation synthesizes photore- alistic facial video from a static source image and an au-fake signal, producing forgeries that current image-based detectors consistently fail to identify.<n>We propose a detection framework that extracts per-video r wave forms via RhythmFormer and trains a suite of lightweight classifiers to distinguish real signals.
  arXiv  Detail & Related papers  (2026-07-23T19:47:15Z)
• Post-Operative Glioma Segmentation via Loss Stabilization, Normalization and Subspace Attention [46.03321798937855]
  We show that the standard Generalized Dice Loss (GDL) is unstable under domain shift.<n>We propose a Subspace-Aware Class Attention (SACA) module that re-calibrates the bottleneck features and raises Enhancing Tumor (ET) sensitivity by 8%.
  arXiv  Detail & Related papers  (2026-07-23T09:59:30Z)
• Fine-tuning LLMs for Passive Depression Severity Estimation from AI Mental Health Dialogue [4.051184721197422]
  Depression is the leading cause of disability worldwide, and early detection of symptom change is essential for timely intervention.<n>We propose a passive, continuous symptom monitoring in AI mental health platforms without requiring users to complete self-report measures.
  arXiv  Detail & Related papers  (2026-06-16T14:28:47Z)
• Amplifying, Not Learning: Fine-Tuned AI Text Detectors Amplify a Pretrained Direction [51.56484100374058]
  Text detectors amplify a pretrained typicality axis; they do not construct an AI-vs-human boundary.<n>On raw encoders before any task supervision, projecting onto centroid(AI)-centroid(HC3) achieves NYT-vs-HC3 AUROC 0.806/0.944/0.834 across three architectures.<n>On RoBERTa-base, raw projection exceeds fine-tuning; on RoBERTa-base, full fine-tuning reduces discrimination below raw on both fluent-formal populations tested.
  arXiv  Detail & Related papers  (2026-05-20T19:08:38Z)
• Neural Uncertainty Principle: A Unified View of Adversarial Fragility and LLM Hallucination [60.197429875410286]
  Adversarial vulnerability in vision and hallucination in large language models are conventionally viewed as separate problems.<n>Formalizing a Neural Uncertainty Principle (NUP) under a loss-induced state, we find that in near-bound regimes, further compression must be accompanied by increased sensitivity dispersion.<n>In vision, masking highly coupled components improves robustness without costly adversarial training.<n>In language, the same prefill-stage probe detects hallucination risk before generating any answer tokens.
  arXiv  Detail & Related papers  (2026-03-20T02:07:10Z)
• From Black Box to Glass Box: Cross-Model ASR Disagreement to Prioto Review in Ambient AI Scribe Documentation [43.148402136307716]
  Cross-model disagreement among heterogeneous ASR systems can act as a reference-free uncertainty signal.<n>We transcribed 50 publicly available medical audio clips with eight ASR systems spanning commercial APIs and open-source engines.<n>Low-agreement regions were enriched for content disagreements, with the content fraction increasing from 53.9% to 73.9% across quintiles of high-risk mass.
  arXiv  Detail & Related papers  (2026-03-02T13:02:13Z)
• I Detect What I Don't Know: Incremental Anomaly Learning with Stochastic Weight Averaging-Gaussian for Oracle-Free Medical Imaging [2.384534878752428]
  We introduce an unsupervised, oracle-free framework that incrementally expands a trusted set of normal samples without any anomaly labels.<n>A frozen pretrained vision backbone is augmented with tiny convolutional adapters, ensuring rapid domain adaptation with negligible computational overhead.<n>On COVID-CXR, ROC-AUC improves from 0.9489 to 0.9982; on Pneumonia CXR, ROC-AUC rises from 0.6834 to 0.8968; and on Brain MRI ND-5, ROC-AUC increases from 0.6041 to 0.7269.
  arXiv  Detail & Related papers  (2025-11-05T23:28:14Z)
• Motion2Meaning: A Clinician-Centered Framework for Contestable LLM in Parkinson's Disease Gait Interpretation [0.8230528541914085]
  Motion2Meaning is a clinician-centered framework that advances Contestable AI.<n>System comprises three key components: a Gait Data Visualization Interface (GDVI), a one-dimensional Convolutional Neural Network (1D-CNN) that predicts Hoehn & Yahr severity stages, and a Contestable Interface (CII)<n>XMED successfully identifies model unreliability by detecting a five-fold increase in explanation discrepancies in incorrect predictions.<n>Our LLM-powered interface enables clinicians to validate correct predictions and successfully contest a portion of the model's errors.
  arXiv  Detail & Related papers  (2025-10-21T12:04:58Z)
• A Novel Attention-Augmented Wavelet YOLO System for Real-time Brain Vessel Segmentation on Transcranial Color-coded Doppler [49.03919553747297]
  We propose an AI-powered, real-time CoW auto-segmentation system capable of efficiently capturing cerebral arteries.<n>No prior studies have explored AI-driven cerebrovascular segmentation using Transcranial Color-coded Doppler (TCCD)<n>The proposed AAW-YOLO demonstrated strong performance in segmenting both ipsilateral and contralateral CoW vessels.
  arXiv  Detail & Related papers  (2025-08-19T14:41:22Z)
• Instant automatic diagnosis of diabetic retinopathy [36.2143325805188]
  OphtAI relies on ensembles of convolutional neural networks trained to recognize eye laterality, detect referable DR and assess DR severity. System was developed and validated using a dataset of 763,848 images from 164,660 screening procedures. OphtAI is safer, faster and more comprehensive than the only AI system authorized by the FDA so far.
  arXiv  Detail & Related papers  (2019-06-12T08:34:57Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.